Author, date and country | Patient group | Study type (level of evidence) | Outcomes | Key results | Study Weaknesses |
---|---|---|---|---|---|
Quarato et al 03/21 Switzerland | 82 consecutive patients with confirmed COVID-19 using a nasopharyngeal swab PCR referred to COVID-19 centre and admitted to the research institute. | Prospective study | Estimate sensitivity of admission LUS for the detection of SARS-CoV-2 lung involvement. Lungs were divided into zones, and direct comparison was made between zones on LUS and CT for specific findings. | Key Results Global LUS sensitivity found to be 52% when detecting COVID-19 pulmonary lesions. LUS sensitivity was 8% for detecting focal opacities (mild disease), 52% for crazy-paving pattern (moderate disease) and up to 100% in extensive subpleural consolidations (severe disease). | Patients already PCR confirmed COVID-19 cases. LUS specificity cannot be calculated as all patients had an abnormal CT scan. |
Haak et al 18/11/2020 Netherlands | 26 patients presenting to the ED with suspected COVID-19 that underwent LUS were included in the study. | Prospective cohort study | Diagnostic accuracy (Sensitivity, Specificity, negative predictive value and positive predictive value and diagnostic accuracy of LUS compared to a laboratory PCR testing and CT scan. | Excluding patients who received a PCR reference standard, we calculated LUS sensitivity, specificity, negative predictive and positive predictive values to be 60%, 62%, 87% and 28% respectively, compared to a CT reference standard. | Only 26 patients in the study underwent both LUS and CT from which we were able to calculate diagnostic accuracy as per the inclusion criteria of this BET. |
Rizzetto et al 05/2021 Italy | 219 patients with PCR +ve COVID and abnormal CT findings. LUS was performed on admission to the ED. | Retrospective study | Lungs were divided into zones and their individual severity score combined. A severity score > 0 was defined as a COVID-19 positive. Diagnostic accuracy of LUS was calculated for each lung zone against CT scores. | Lung ultrasound sensitivity and specificity using CT scan as a reference standard were 75% and 66% respectively. | Selection of only COVID +ve patients could lead to overestimation of diagnostic accuracy LUS performed by different experienced clinicians introduces issues of inter operator reliability. |
Schmid et al 07/12/2020 Germany | 31 patients presenting to the ED with respiratory symptoms. patients underwent LUS, CT, and PCR. | Retrospective cohort study | Diagnostic accuracy (Sensitivity, Specificity, negative predictive value and positive predictive value and diagnostic accuracy of LUS compared to a laboratory PCR testing and as a subgroup study, to CT scan, for which sensitivity and specificity were calculated. Positive and negative predictive values can be calculated from the data. | LUS sensitivity and specificity when compared to a CT scan was 65.0% and 72.7% respectively. From our calculations, positive and negative predictive values are 81.3% and 53.3% respectively | Only 31 patients of the 2236 patients in the study underwent both CT and LUS and were eligible for this BET. Funded by multiple external sources. Authors claim no conflict of interest. |
Tung-Chen et al 13/07/2020 Spain | 51 clinically suspicious PCR negative patients presenting to ED underwent CT and LUS | Prospective Study | Assess the diagnostic accuracy of LUS using a ROC curve analysis. | ROC curve analysis described LUS as having a sensitivity, specificity, positive and negative predictive values of 100%, 78.6%, 92.5% and 100% respectively vs CT. | No blinding of clinicians to reference standard. PCR positive patients were not given CT scans, suggesting patients with only mild disease were included. |
Karagöz et al 12/2020 Turkey | 72 patients presenting to ED with suspected COVID-19 | Prospective, cross sectional cohort study. | To assess the diagnostic accuracy of LUS by using the BLUE protocol to assess the LUS and compare these findings to those on the CT. | LUS 96.9% (95%CI 84.2-99.9) sensitive 92.3% (95%CI 79.1-98.3%) specific The positive and negative predictive values were 84.3% (95%CI 64.5%-94.1%) and 98.6% (95%CI 91.1%-99.8%) respectively. | Wide confidence intervals No measure of interrater reliability |
Walsh et al 28/09/2020 USA | 49 patients over 14 years of age with no relevant underlying disease retrospectively selected on the basis of having an ultrasound scan performed and reported on before CT scanning was performed. | Retrospective Study | Reviewed records of eligible patients who underwent LUS for COVID-19 diagnosis. Outcome was the corroboration of treating clinician’s LUS findings with CT scan results. | 49 records met inclusion criteria, 10% had COVID-19 changes on LUS. LUS found to be 92-100% sensitive and 37-80% specific at detecting COVID-19 related lung changes compared to CT. | Patients not randomly selected Very broad estimate of specificity of LUS. |
Benchoufi et al 05/2020 France | 107 patients presenting to 3 emergency departments with suspected or confirmed COVID-19 were given a CT scan, and LUSs by two physicians, blinded to each other and the CT. | Multicenter, observational non-randomised study | LUS conducted on 8 lung regions scored independently between 0-3, totalling a score of 0-24. This was compared to corresponding CT scans scored based on signs of interstitial pneumonia. Some patients were dual assessed by experienced and trainee LUS operators to ascertain differences between novice and experienced LUS operators. | 86 of 107 patients had positive CT findings. Scores between LUS and CT showed a strong concordance. 17 patients excluded from this due to incomplete data. LUS showed 95% sensitivity and 83% specificity as compared to CT. 48 cases were dual assessed. The weighted kappa (0.62-8.1) showed a strong concordance with results between the trainee and experienced ultrasound operators. | Not peer reviewed, ahead of print. Lead author has declared competing interests as a cofounder and stakeholder in a company producing handheld ultrasound devices for clinical use. Study not randomised |
Poggiali et al 03/2020 Italy | 12 COVID positive patients presenting to the emergency department. Patients were given CT and LUS scans. | Observational study | Results of CT and LUS scans were assessed for correlation. | All LUS scans showed B-lines in accordance with COVID-19. CT scans showed ‘strong correlation’, with 5/12 patients showing crazy-paving patterning. | Small sample size (12). Limited quantitative analysis No statistical analysis or calculations of diagnostic accuracy. |
Yang et al 25/05/2020 China | 29 patients with laboratory confirmed COVID-19 underwent simultaneous CT and ultrasound scan. Ultrasound scans were divided into 12 regions, and mapped onto the corresponding CT scans. Results were interpreted in terms of regions. | Retrospective study | Direct comparison of 12 lung zones from each patient’s LUS findings to CT findings in lab confirmed COVID-19 patients. | Total of 540 lung regions were scanned by ultrasound. 63% of regions displayed signs of COVID-19 related changes. 95% of these regions showed B-Lines. CT scan detected changes in 38.7% of the total number of regions scanned. LUS is more sensitive at detecting COVID-19 lung changes than CT scan, in laboratory confirmed cases. | Reported in terms of regions makes it difficult to know the sensitivity and specificity on a patient by patient basis. |